Esser et al., "N-terminale Cyclisierung Von Peptiden mit N, N' Carbonyldimidazole oder N, N'-thiocarbonyldimidazol", Agnew. Chem. 1978, vol. 90, No. 6, pp. 495-496. |
Mould et al., "The CS5 Peptide Is a Second Site in the IIICS Region of Fibronectin Recognized by the Integrin .alpha..sub.4 .beta..sub.1 " J. of Biol. Chem., vol. 266, No. 6, pp. 3579-3585, Feb. 25, 1991. |
Esser, F. and Roos, O. "N-Terminal Cyclization of Peptides with N,N'-Carbonyldiimidazole or N,N'-Thiocarbonyldiimidazole." Angew. Chem. Int. Ed. Engl. 17(6):467-468 (1978). |
Komoriya, Akira et al., "The Minimal Essential Sequence for a Major Cell Type-Specific Adhesion Site (CS1) Within the Alternatively Splice Type III Connecting Segment Domain of Fibronectin is Leucine-Aspartic Acid-Valine." J. Biol. Chem. 266:15075-15079 (1991). |
Elices, Mariano "The Integrin .alpha..sub.4 .beta..sub.1 (VLA-4) as a Therapeutic Target." Cell Adhesion and Human Disease. Wiley, Chichester (Ciba Foundation Symposium 189) pp. 79-90 (1995). |
Nowlin, Dawn M., "A Novel Cyclic Pentapeptide Inhibits .alpha.4.beta.1 and .alpha.5.beta.1 Integrin-mediated Cell Adhesion." J. Biol. Chem. 268:20352-20359 (1993). |
Mousa, Shaker A. et al., "Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPllB/IIIa Receptor Antagonist." Clin. Pharm. 83:373-382 (1993). |
Cardarelli, Pina et al., "Cyclic RGD Peptide Inhibits .alpha.4.beta.1 Interaction with Connecting Segment 1 and Vascular Cell Adhesion Molecule." J. Biol. Chem. 269:18668-18673 (1994). |
Pfaff, Martin et al., "Seletive Recognition of Cyclic RGD Peptides of NMR Defined Conformation by .alpha.V.beta.3, .alpha.5.beta.1 Integrins." J. Biol. Chem. 269:20233-20238 (1994). |